Activation of molecular oxygen during the reactions of chromium(VI/V/IV) with biological reductants: Implications for chromium-induced genotoxicities

Journal of the American Chemical Society

Volumn 120, Issue 27, 1998, Pages 6704-6714

  Lay, Peter A ^a   Levina, Aviva ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CHROMIUM; CYSTEINE; GLUTATHIONE; TROLOX C;

ARTICLE; CIRCULAR DICHROISM; ELECTRON SPIN RESONANCE; GENOTOXICITY; IN VITRO STUDY; MODEL; OXIDATION; REACTION ANALYSIS; STOICHIOMETRY;

EID: 0032527711     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja974240z     Document Type: Article

References (94)

1. 2: = 2-ethyl-2-hydroxybutanoic acid; GSH = glutathione (γ-glutamylcysteinylglycine); HEPES = N-[2-hydroxyethyl]-piperazine-N′-[2-ethanesulfonic acid]; Red = reductant; SOD = Superoxide dismutase; Trolox = 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid.
2. IARC. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol. 49. Chromium, Nickel and Welding; International Agency on the Research of Cancer: Lyon, France, 1990.
3. For the recent review of the problem, see: (a) Cieślak-Golonka, M. Polyhedron 1996, 15, 3667-3689. (b) Kortenkamp, A.; Casadevall, M.; Da Cruz Fresco, P.; Shayer, R. O. J. NATO ASI Series, Ser. 2 1997, 26, 15-34. (c) Stearns, D. M.; Wetterhahn, K. E. NATO ASI Series, Ser. 2 1997, 26, 55-72, and references therein.
4. For the recent review of the problem, see: (a) Cieślak-Golonka, M. Polyhedron 1996, 15, 3667-3689. (b) Kortenkamp, A.; Casadevall, M.; Da Cruz Fresco, P.; Shayer, R. O. J. NATO ASI Series, Ser. 2 1997, 26, 15-34. (c) Stearns, D. M.; Wetterhahn, K. E. NATO ASI Series, Ser. 2 1997, 26, 55-72, and references therein.
5. For the recent review of the problem, see: (a) Cieślak-Golonka, M. Polyhedron 1996, 15, 3667-3689. (b) Kortenkamp, A.; Casadevall, M.; Da Cruz Fresco, P.; Shayer, R. O. J. NATO ASI Series, Ser. 2 1997, 26, 15-34. (c) Stearns, D. M.; Wetterhahn, K. E. NATO ASI Series, Ser. 2 1997, 26, 55-72, and references therein.
6. Connett, P. H.; Wetterhahn, K. E. Struct. Bond. (Berlin) 1983, 54, 93-124.
7. (a) Farrell, R. P.; Judd, R. J.; Lay, P. A.; Dixon, N. E.; Baker, R. S. U.; Bonin, A. M. Chem. Res. Toxicol. 1989, 2, 227-229.
8. (b) Barr-David, G.; Hambley, T. W.; Irwin, J. A.; Judd, R. J.; Lay, P. A.; Martin, B. D.; Bramley, R.; Dixon, N. E.; Hendry, P.; Ji, J.-Y.; Baker, R. S. U.; Bonin, A. M. Inorg. Chem. 1992, 31, 4906-4908.
9. (c) Dillon, C. T.; Lay, P. A.; Bonin, A. M.; Cholewa, M.; Legge, G. J. F.; Collins, T. J.; Kostka, K. L. Chem. Res. Toxicol. 1998, 11, 119-129.
10. (a) Liu, K. J.; Shi, X.; Jiang, J.; Goda, F.; Dalal, N.; Swartz, H. M. Ann. Clin. Lab. Sci. 1996, 26, 176-184.
11. (b) Liu, K. J.; Mader, K.; Shi, X. L.; Swartz, H. M. Magn. Res. Med. 1997, 38, 524-526.
12. Sugden, K. D.; Burris, R. B.; Rogers, S. J. Mutat. Res. 1990, 244, 239-244.
13. (a) Da Cruz Fresco, P.; Kortenkamp, A. Carcinogenesis 1994, 15, 1773-1778.
14. (b) Kortenkamp, A.; Casadevall, M.; Faux, S. P.; Jenner, A.; Shayer, R. O. J.; Woodbridge, N.; O'Brien, P. Arch. Biochem. Biophys. 1996, 329, 199-207.
15. Kortenkamp, A.; Oetken, G.; Beyersmann, D. Mutat. Res. 1990, 232, 155-161.
16. 2 + DMPO systems, for example: (a) Liu, K. J.; Shi, X.; Dalal, N. S. Biochem. Biophys. Res. Commun. 1997, 235, 54-58. However, analogous EPR signals can be observed due to the direct reactions of DMPO with Cr in high oxidation states: (b) Judd, R. J. Ph.D. Thesis, University of Sydney, 1992. (c) Sugden, K. D.; Wetterhahn, K. E. Inorg. Chem. 1996, 35, 651-657.
17. 2 + DMPO systems, for example: (a) Liu, K. J.; Shi, X.; Dalal, N. S. Biochem. Biophys. Res. Commun. 1997, 235, 54-58. However, analogous EPR signals can be observed due to the direct reactions of DMPO with Cr in high oxidation states: (b) Judd, R. J. Ph.D. Thesis, University of Sydney, 1992. (c) Sugden, K. D.; Wetterhahn, K. E. Inorg. Chem. 1996, 35, 651-657.
18. 2 + DMPO systems, for example: (a) Liu, K. J.; Shi, X.; Dalal, N. S. Biochem. Biophys. Res. Commun. 1997, 235, 54-58. However, analogous EPR signals can be observed due to the direct reactions of DMPO with Cr in high oxidation states: (b) Judd, R. J. Ph.D. Thesis, University of Sydney, 1992. (c) Sugden, K. D.; Wetterhahn, K. E. Inorg. Chem. 1996, 35, 651-657.
19. 2 reactions: (a) Dickman, M. H.; Pope, M. T. Chem. Rev. 1994, 94, 569-584, and references therein. (b) Zhang, L.; Lay, P. A. Inorg. Chem. 1998, 37, 1729-1733.
20. 2 reactions: (a) Dickman, M. H.; Pope, M. T. Chem. Rev. 1994, 94, 569-584, and references therein. (b) Zhang, L.; Lay, P. A. Inorg. Chem. 1998, 37, 1729-1733.
21. (a) Zhang, L.; Lay, P. A. J. Am. Chem. Soc. 1996, 118, 12624-12637.
22. (b) Zhang, L.; Lay, P. A. J. Biol. Inorg. Chem., submitted.
23. O'Brien, P.; Woodbridge, N. Polyhedron 1997, 16, 2897-2899.
24. Chen, F.; Ye, J.; Zhang, X.; Rojanasakul, Y.; Shi, X. Arch. Biochem. Biophys. 1997, 338, 165-172.
25. Trudgill, P. W. In CRC Handbook of Methods for Oxygen Radical Research; CRC Press: Boca Raton, FL, 1985; pp 329-342.
26. Rice-Evans, C.; Miller, N. J. Methods Enzymol. 1994, 234, 279-293.
27. (a) Maeder, M.; Zuberbuhler, A. D. Anal. Chem. 1990, 62, 2220-2224.
28. (b) Beechem, J. M. Methods Enzymol. 1992, 210, 37-55.
29. (c) Henry, E. R.; Hofrichter, J. Methods Enzymol. 1992, 210, 129-192.
30. Lay, P. A.; Levina, A. Inorg. Chem. 1996, 35, 7709-7717.
31. (a) Leonard, A.; Lauwerys, R. R. Mutat. Res. 1980, 75, 49-62.
32. (b) Leonard, A.; Lauwerys, R. R. Mutat. Res. 1980, 76, 227-239.
33. Krumpolc, M.; Roček, J. J. Am. Chem. Soc. 1979, 101, 3206-3209.
34. Brauer, G. Handbook of Preparative Inorganic Chemistry, 2nd ed.; Academic: New York, 1963; Vol. 2, p 1391.
35. Buettner, G. R. Methods Enzymol. 1990, 186, 125-127.
36. Khomutov, N. E.; Konnik, E. I. Zh. Fiz. Khim. 1974, 48, 620-625; English trans.: Rus. J. Phys. Chem. 1974, 48, 359-362.
37. Khomutov, N. E.; Konnik, E. I. Zh. Fiz. Khim. 1974, 48, 620-625; English trans.: Rus. J. Phys. Chem. 1974, 48, 359-362.
38. 5a,b
39. 2 consumption experiments.
40. Generation, stability and UV-visible spectra of Cr(IV)-ehba complexes are described in the following: (a) Ghosh, M. C.; Gould, E. S. Inorg. Chem. 1991, 30, 491-494. (b) Codd, R.; Lay, P. A.; Levina, A. Inorg. Chem. 1997, 36, 5440-5448.
41. Generation, stability and UV-visible spectra of Cr(IV)-ehba complexes are described in the following: (a) Ghosh, M. C.; Gould, E. S. Inorg. Chem. 1991, 30, 491-494. (b) Codd, R.; Lay, P. A.; Levina, A. Inorg. Chem. 1997, 36, 5440-5448.
42. 2 consumption experiments.
43. 2) did not change in the presence of 1.0 mM of Cr(VI), Cr(V), or Cr(IV) (pH = 7.0-7.5).
44. Aebi, H. Methods Enzymol. 1984, 105, 121-126.
45. Vogel, A. I. Text-Book of Quantitative Inorganic Analysis. Theory and Practice, 2nd ed.; Longmans, Green and Co.; London, U.K., 1953; pp 348-349.
46. - in aqueous solutions: Krumpolc, M.; Roček, J. Inorg. Chem. 1985, 24, 617-621.
47. Mitewa, M.; Bontchev, P. R. Coord. Chem. Rev. 1985, 61, 241-272.
48. Pro-Kineticist, Version 4.10; Applied Photophysics Ltd.: Leatherhead, U.K., 1996.
49. Haupt, G. W. Natl. Bur. Stand. Circ. (U.S.) 1952, 48, 414-423.
50. Ellman, G. L. Arch. Biochem. Biophys. 1959, 82, 70-77.
51. Origin. Technical Graphics and Data Analysis for Windows, Version 4.1; Microcal Software Inc.: Northampton, U.S., 1996.
52. WIN-EPR, Version 921201; Bruker-Franzen Analytic GmbH.: Bremen, Germany, 1996.
53. 2 consumptions were observed for the Cr(VI/V/IV) + buffer systems.
54. Preliminary kinetic experiments have shown that the rates of Cr(V) reactions with catalase, SOD, or DMPO under the studied conditions were insignificant in comparison with those for the Cr(V) + Cys reaction.
55. 4.
56. Tsou, T.-C.; Yang, J.-L. Chem. Biol. Interact. 1996, 102, 133-153.
57. 0 = 25 mM.
58. 0 ratios, these reactions possessed autocatalytic behavior: (a) Ghosh, S. K.; Bose, R. N.; Gould, E. S. Inorg. Chem. 1987, 26, 3722-3727. (b) Ghosh, S. K.; Bose, R. N.; Gould, E. S. Inorg. Chem. 1987, 26, 2684-2687. However, autocatalysis was not observed under the conditions used in this work.
59. 0 ratios, these reactions possessed autocatalytic behavior: (a) Ghosh, S. K.; Bose, R. N.; Gould, E. S. Inorg. Chem. 1987, 26, 3722-3727. (b) Ghosh, S. K.; Bose, R. N.; Gould, E. S. Inorg. Chem. 1987, 26, 2684-2687. However, autocatalysis was not observed under the conditions used in this work.
60. 26,31 The simplest kinetic schemes, applied here (Table 2), do not reflect true mechanisms of these reactions. The kinetic data (17-20 in Table 2) are given only for comparison with the reactions in the presence of Red (1-16 in Table 2).
61. Dalal, N. S.; Millar, J. M.; Jagadeesh, M. S.; Seehra, M. S. J. Chem. Phys. 1981, 74, 1916-1923.
62. The use of the relatively stable Cr(V) and Cr(IV) complexes mimics intracellular conditions, where Cr(V/IV) species are likely to be stabilized by complexation with a variety of ligands, including carbohydrates and 2-hydroxycarboxylates (Barr-David, G.; Bramley, R.; Brumby, S.; Charara, M.; Codd, R.; Farrell, R. P.; Hanson G. R.; Irwin, J. A.; Ji, J.-Y.; Lay, P. A. J. Chem. Soc., Faraday Trans. 1995, 91, 1207-1216).
63. 26b however, application of the stopped-flow technique in the current work allowed to obtain definitive evidence for their existence. The equilibrium (eq 2) is probably achieved within a deadtime of the stopped-flow experiment.
64. 26b
65. 12 and complexes with Trolox oxidation product, 2-hydroxy-2-methyl-4-(2,5,6-trimethyl-2,4-dioxo-2,5-cyclohexadienyl)butanoic acid (Dalla-Pozza, A.-M. B.Sc. Honours Thesis, University of Sydney, 1996).
66. 12 and complexes with Trolox oxidation product, 2-hydroxy-2-methyl-4-(2,5,6-trimethyl-2,4-dioxo-2,5-cyclohexadienyl)butanoic acid (Dalla-Pozza, A.-M. B.Sc. Honours Thesis, University of Sydney, 1996).
67. 12 and (c) complexes with Trolox oxidation product, 2-hydroxy-2-methyl-4-(2,5,6-trimethyl-2,4-dioxo-2,5-cyclohexadienyl)butanoic acid (Dalla-Pozza, A.-M. B.Sc. Honours Thesis, University of Sydney, 1996).
68. Cotton, F. A.; Wilkinson, G. Advanced Inorganic Chemistry, 5th ed.; John Wiley & Sons: New York, 1988; p 687.
69. Since all the reductants used possess a number of potential donor groups (see Scheme 2), such mixtures of Cr(V/IV) species may be very complex.
70. Bielski, B. H. J. In Ascorbic Acid: Chemistry, Metabolism and Uses; Seib, P. A., Tobbert, B. M., Eds.; Advances in Chemistry Series, American Chemical Society: New York, 1982; Vol. 200, pp 81-99.
71. Thomas, M. J.; Bielski, B. D. J. J. Am. Chem. Soc. 1989, 111, 3315-3319.
72. 52,53 This is because the applied kinetic schemes (Table 2) did not take into account the second-order disproportionation reactions of the anionradicals (eq 17 in Scheme 2).
73. Asmus K.-D. Methods Enzymol. 1990, 186, 168-180.
74. Further slow oxidation of DHAA leads to degradation products, such as 2,3-diketogulonic acid: Davies, M. B.; Austin, J.; Partridge, D. A. Vitamin C: Its Chemistry and Biochemistry; The Royal Society of Chemistry: Cambridge, U.K., 1991; pp 66-73, 115-146.
75. Bose, R. N.; Fonkeng, B.; Barr-David, G.; Farrell, R. P.; Judd, R. J.; Lay, P. A.; Sangster, D. F. J. Am. Chem. Soc. 1996, 118, 7139-7144.
76. This reaction (eq 18) may be related to the formation of carbon-based radicals during the Cr(VI) + AsA reactions, observed in EPR experiments with the spin trap DMPO (Stearns, D. M.; Wetterhahn, K. E. Chem. Res. Toxicol. 1994, 7, 219-230). Preliminary EPR experiments in the presence of DMPO led to similar EPR signals in the reactions of Cr(VI) or Cr(V) with AsA (pH 7.5); however, no EPR signals were observed for the Cr(IV) + AsA + DMPO reactions (Levina, A., unpublished results).
77. Two weak absorbance maxima in visible range (400-450 nm and 550-600 nm) are characteristic for octahedral Cr(III) complexes in aqueous solutions (Larkworthy, L. F.; Nolan, K. B.; O'Brien, P. In Comprehensive Coordination Chemistry; Wilkinson, G., Gillard, R. D., McCleverty, J. A., Eds.; Pergamon Press: Oxford, U.K., 1987; Vol. 3, pp 699-969).
78. Karoui, H.; Hogg, N.; Joseph, J.; Kalyanaraman, B. Arch. Biochem. Biophys. 1996, 330, 115-124.
79. Winterbourn, C. C.; Metodiewa, D. Arch. Biochem. Biophys. 1994, 314, 284-290.
80. Brunori, M.; Rotilio, G. Methods Enzymol. 1984, 105, 22-35.
81. Quijano, C.; Alvarez, B.; Gatti, R. M.; Augusto, O.; Radi, R. Biochem. J. 1997, 322, 167-173.
82. Lefebvre, Y.; Pézerat, H. Chem. Res. Toxicol. 1992, 5, 461-463.
83. Perez-Benito, J. F.; Arias, C.; Lamrhari, D. New J. Chem. 1994, 18, 663-666.
84. Formation of Cr(II) intermediates is well documented for the reactions of Cr(VI) with alcohols in strongly acidic media: Scott, S. L.; Bakac, A.; Espenson, J. H. J. Am. Chem. Soc. 1992, 114, 4205-4213.
85. 12.
86. 12.
87. Zhang, L. Ph.D. Thesis, University of Sydney, 1998.
88. Kadiiska, M. B.; Xiang, Q.-H.; Mason, R. P. Chem. Res. Toxicol. 1994, 7, 800-805, and references therein.
89. Bakac, A.; Wang, W.-D. J. Am. Chem. Soc. 1996, 118. 10325-10326.
90. Dillon, C. T.; Lay, P. A.; Cholewa, M.; Legge, G. J. F.; Bonin, A. M.; Collins, T. J.; Kostka, K. L.; Shea-McCarthy, G. Chem. Res. Toxicol. 1997, 10, 533-535.
91. 4, 37 °C).
92. 73.
93. (a) Sugden, K. D.; Wetterhahn, K. E. J. Am. Chem. Soc. 1996, 118, 10811-10818.
94. (b) Sugden, K. D.; Wetterhahn, K. E. Chem. Res. Toxicol. 1977, 10, 1397-1406.